Beximco Pharma, is a generic drug player committed to providing access to affordable medicines. It's state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets around the world. The company received US Food and Drug Administration (FDA) approval for flecainide acetate 50mg, 100mg and 150mg tablets. The company announced this last week. Flecainide acetate is the generic equivalent to 3M Pharmaceuticals' 'Tambocor'. Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. Today Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first